相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CREMa suppresses spleen tyrosine kinase expression in normal but not systemic lupus erythematosus T cells
Debjani Ghosh et al.
ARTHRITIS AND RHEUMATISM (2012)
Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus
Y. Molad et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Treatment of Rheumatoid Arthritis With a Syk Kinase Inhibitor A Twelve-Week, Randomized, Placebo-Controlled Trial
Michael E. Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2008)
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus
Frances Rena Bahjat et al.
ARTHRITIS AND RHEUMATISM (2008)
Differential Expression and Molecular Associations of Syk in Systemic Lupus Erythematosus T Cells
Sandeep Krishnan et al.
JOURNAL OF IMMUNOLOGY (2008)
Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene
PR Manna et al.
MOLECULAR ENDOCRINOLOGY (2004)
Reconstitution of deficient T cell receptor ζ chain restores T cell signaling and augments T cell Receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus
MP Nambiar et al.
ARTHRITIS AND RHEUMATISM (2003)
Targeting JNK for therapeutic benefit: From JuNK to gold?
AM Manning et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Transcriptional regulation of the mouse steroidogenic acute regulatory protein gene by the cAMP response-element binding protein and steroidogenic factor 1
PR Manna et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2003)
The FcRγ subunit and Syk kinase replace the CD3ζ-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells
S Krishnan et al.
JOURNAL OF IMMUNOLOGY (2003)
JNK is required for effector T-cell function but not for T-cell activation
C Dong et al.
NATURE (2000)
分享论文
